IP Library Granted Patent US 7,004,933
Granted Patent B2
US 7,004,933 · App. 09/876,157 · Granted Feb 28, 2006

Ultrasound enhancement of percutaneous drug absorption

Assignee: Light BioScience L.L.C.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,004,933
App. No.
09/876,157
Granted
Feb 28, 2006
Kind
B2
Abstract

A system for enhancing and improving the transcutaneous or transdermal delivery of topical chemicals or drugs. A disposable container contains a substantially sterile unit dose of an active agent adapted for a single use in a medical treatment. The unit dose is formulated to enhance transport of the active agent through mammalian skin when the active agent is applied to the skin and the skin is exposed to light and/or ultrasound defined by at least one specific parameter.

Claims (8)

1. A method for enhancing the transport of an active agent through mammalian skin, wherein the skin comprises a stratum corneum, the method comprising:

exposing the skin to ultrasound,

applying an active agent to the skin, and

modifying at least portion of the stratum corneum substantially prior to the step of exposing the skin to ultrasound, wherein the step of modifying at least a portion of the stratum corneum comprises at least one of the steps of:

removing at least a follicular plug from the stratum corneum,

removing at least skin debris from the stratum corneum, and

removing at least a portion of the stratum corneum,

wherein the stratum corneum is characterized by a structure, a function, a thickness and a permeability and wherein the step of modifying at least a portion of the stratum corneum comprises at least one of the steps of stripping, removing, thinning and diminishing at least one of the structure, function, thickness and permeability of the stratum corneum by at least one of a mechanical, abrasive, photo acoustic, ablative, thermal, chemical, abrasive and enzymatic method.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 21, 2014
From: GENTLEWAVES LLC
To: L'OREAL USA, INC.
Reel/Frame 033349/0119 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 21, 2014
From: L'OREAL USA, INC.
To: L'OREAL S.A.
Reel/Frame 033349/0152 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 18, 2009
From: GENTLEWAVES LIMITED
To: GENTLE WAVES LLC
Reel/Frame 023668/0411 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 17, 2009
From: GENTLE WAVES LLC
To: GENTLEWAVES LIMITED
Reel/Frame 023660/0950 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 9, 2009
From: LIGHT BIOSCIENCE LLC
To: GENTLEWAVES LLC
Reel/Frame 022928/0329 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2003
From: MCDANIEL, DAVID H.
To: LIGHT BIOSCIENCE LLC
Reel/Frame 014409/0670 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 30, 2002
From: MCDANIEL, DR. DAVID H.
To: LIGHT BIOSCIENCE, L.L.C.
Reel/Frame 013138/0449 →
Continuity (3)
Division 0916868300 · Oct 9, 1998
Continuation In Part 0908714600 · May 29, 1998
Related Publication 20020120225A1 · Aug 29, 2002